.
COVID-19
EN
RU
English
About us
History
Infrastructure
Quality management
Partners
Advantages
Ethical Business Conduct
Mission and values
Case studies
Documents
Network sites
Organizational chart
Services
Phase I studies
Phase II-III studies
Bioequivalence studies
Scientific research
LEC approval
Clinical Trial At-Home Services
Study assessment
Experience
Volunteers
Patients
News
Contact
Careers
For clients
For doctors
For patients
For volunteers
We recruits for patients with nonresectable or metastatic melanoma
«BioEq» recruits
for patients with nonresectable or metastatic melanoma to participate in a phase I clinical study.
Study medication
:
monoclonal antibody
CTLA-4
.
We invite male and female patients, elder 18 age, with:
Histological verificate nonresectable or metastatic melanoma
Measurable control tumor nidus
Please contact us at
8-812-945-22-32
to learn more.
